The award will help Gokel and his group, Upaya Pharmaceuticals, progress their antibiotic resistance technology along the path toward commercialization.

The award will help Gokel and his group, Upaya Pharmaceuticals, progress their antibiotic resistance technology along the path toward commercialization.
The award will help Gokel and his group, Upaya Pharmaceuticals, progress their antibiotic resistance technology along the path toward commercialization.
The award will help Gokel and his group, Upaya Pharmaceuticals, progress their antibiotic resistance technology along the path toward commercialization.
Nichols is investigating proteins linked to inflammation in the brain that occurs as part of the neurodegenerative disease.